Literature DB >> 11016337

Pulmonary function after lobectomy: video-assisted thoracic surgery versus thoracotomy.

M Nakata1, H Saeki, N Yokoyama, A Kurita, W Takiyama, S Takashima.   

Abstract

BACKGROUND: Whether video-assisted thoracic surgery (VATS) improves postoperative pulmonary function is still controversial. We compared postoperative pulmonary function after VATS lobectomy and standard lobectomy.
METHODS: Eleven patients who had undergone standard lobectomy and 10 patients who had undergone VATS lobectomy were studied. Arterial blood gas analyses were performed on the 4th, 7th, and 14th postoperative days. Pulmonary function, including forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1.0), and peak flow rate (PFR) were measured on the 7th and 14th postoperative days (early phase), and approximately 1 year after surgery (late phase).
RESULTS: Pulmonary function, as assessed with arterial oxygen partial pressure (PaO2) (p = 0.054), arterial oxygen saturation (O2SAT) (p = 0.063), FVC (p = 0.10), and FEV1.0 (p = 0.08), was better after VATS lobectomy than after thoracotomy on the 7th postoperative day. PFR was significantly better after VATS on both the 7th and 14th postoperative days (p = 0.008 and p = 0.03, respectively).
CONCLUSIONS: VATS lobectomy had advantages on early postoperative pulmonary function. We conclude that VATS lobectomy is a beneficial alternative to standard thoracotomy, especially for patients with poor pulmonary reserve.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016337     DOI: 10.1016/s0003-4975(00)01513-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  42 in total

Review 1.  Video-assisted thoracic surgery for lung cancer.

Authors:  Sanghoon Jheon; Hee Chul Yang; Sukki Cho
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

2.  Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy.

Authors:  Mark F Berry; Nestor R Villamizar-Ortiz; Betty C Tong; William R Burfeind; David H Harpole; Thomas A D'Amico; Mark W Onaitis
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

3.  Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients.

Authors:  Mark W Onaitis; Rebecca P Petersen; Stafford S Balderson; Eric Toloza; William R Burfeind; David H Harpole; Thomas A D'Amico
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

4.  Video-atlas of thoracoscopic formal lung resections emulating traditional open techniques - Editor's comments.

Authors:  Kumud Dhital
Journal:  Ann Cardiothorac Surg       Date:  2012-05

5.  Techniques of VATS lobectomy.

Authors:  John D Mitchell
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

6.  Current costs of video-assisted thoracic surgery (VATS) lobectomy.

Authors:  Tunc Lacin; Scott Swanson
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

7.  Long-term respiratory function recovery in patients with stage I lung cancer receiving video-assisted thoracic surgery versus thoracotomy.

Authors:  Tae Yun Park; Young Sik Park
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

8.  Comparison in prognosis after VATS lobectomy and open lobectomy for stage I lung cancer: retrospective analysis focused on a histological subgroup.

Authors:  S Sawada; E Komori; M Yamashita; M Nakata; R Nishimura; N Teramoto; Y Segawa; T Shinkai
Journal:  Surg Endosc       Date:  2007-02-16       Impact factor: 4.584

Review 9.  Surgical management of lung cancer.

Authors:  Adam Lackey; Jessica S Donington
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

10.  Is intravenous patient controlled analgesia enough for pain control in patients who underwent thoracoscopy?

Authors:  Jie Ae Kim; Tae Hyeong Kim; Mikyung Yang; Mi Sook Gwak; Gaab Soo Kim; Myung Joo Kim; Hyun Sung Cho; Woo Seok Sim
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.